KR102259117B1 - 시트 성형체 및 지혈재 - Google Patents

시트 성형체 및 지혈재 Download PDF

Info

Publication number
KR102259117B1
KR102259117B1 KR1020147031716A KR20147031716A KR102259117B1 KR 102259117 B1 KR102259117 B1 KR 102259117B1 KR 1020147031716 A KR1020147031716 A KR 1020147031716A KR 20147031716 A KR20147031716 A KR 20147031716A KR 102259117 B1 KR102259117 B1 KR 102259117B1
Authority
KR
South Korea
Prior art keywords
molded article
fibrinogen
thrombin
polymer
laminated sheet
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
KR1020147031716A
Other languages
English (en)
Korean (ko)
Other versions
KR20150020536A (ko
Inventor
유카코 가게야마
겐타로 후지나가
아유코 야마구치
유스케 아키야마
아키토시 오오노
스스무 혼다
마코토 사타케
히로아키 가네코
다카유키 이마무라
료이치 가와무라
마사키 히라시마
Original Assignee
데이진 가부시키가이샤
데이진 화-마 가부시키가이샤
케이엠 바이올로직스 가부시키가이샤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 데이진 가부시키가이샤, 데이진 화-마 가부시키가이샤, 케이엠 바이올로직스 가부시키가이샤 filed Critical 데이진 가부시키가이샤
Publication of KR20150020536A publication Critical patent/KR20150020536A/ko
Application granted granted Critical
Publication of KR102259117B1 publication Critical patent/KR102259117B1/ko
Assigned to 데이진 가부시키가이샤 reassignment 데이진 가부시키가이샤 권리지분의 전부이전등록 Assignors: 데이진 화-마 가부시키가이샤
Assigned to 케이엠 바이올로직스 가부시키가이샤 reassignment 케이엠 바이올로직스 가부시키가이샤 권리지분의 전부이전등록 Assignors: 데이진 가부시키가이샤
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00—Bandages or dressings; Absorbent pads
    • A61F13/00051—Accessories for dressings
    • A61F13/00063—Accessories for dressings comprising medicaments or additives, e.g. odor control, PH control, debriding, antimicrobic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00—Bandages or dressings; Absorbent pads
    • A61F13/02—Adhesive bandages or dressings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36—Blood coagulation or fibrinolysis factors
    • A61K38/363—Fibrinogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A61K38/4833—Thrombin (3.4.21.5)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/44—Medicaments
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/001—Use of materials characterised by their function or physical properties
    • A61L24/0015—Medicaments; Biocides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/001—Use of materials characterised by their function or physical properties
    • A61L24/0036—Porous materials, e.g. foams or sponges
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/001—Use of materials characterised by their function or physical properties
    • A61L24/0042—Materials resorbable by the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
    • A61L24/043—Mixtures of macromolecular materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
    • A61L24/10—Polypeptides; Proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
    • A61L26/0028—Polypeptides; Proteins; Degradation products thereof
    • A61L26/0042—Fibrin; Fibrinogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
    • A61L26/0052—Mixtures of macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061—Use of materials characterised by their function or physical properties
    • A61L26/0066—Medicaments; Biocides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061—Use of materials characterised by their function or physical properties
    • A61L26/0085—Porous materials, e.g. foams or sponges
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061—Use of materials characterised by their function or physical properties
    • A61L26/009—Materials resorbable by the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00—Bandages or dressings; Absorbent pads
    • A61F2013/00361—Plasters
    • A61F2013/00365—Plasters use
    • A61F2013/00463—Plasters use haemostatic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/25—Peptides having up to 20 amino acids in a defined sequence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/252—Polypeptides, proteins, e.g. glycoproteins, lipoproteins, cytokines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/418—Agents promoting blood coagulation, blood-clotting agents, embolising agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00—Materials characterised by their function or physical properties
    • A61L2400/04—Materials for stopping bleeding

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Materials Engineering (AREA)
  • Medicinal Chemistry (AREA)
  • Surgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Vascular Medicine (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Dispersion Chemistry (AREA)
  • Zoology (AREA)
  • Diabetes (AREA)
  • Inorganic Chemistry (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Laminated Bodies (AREA)
  • Medicinal Preparation (AREA)
  • Polymers & Plastics (AREA)
KR1020147031716A 2012-05-14 2013-05-13 시트 성형체 및 지혈재 Active KR102259117B1 (ko)

Applications Claiming Priority (11)

Application Number Priority Date Filing Date Title
JPJP-P-2012-110394 2012-05-14
JP2012110391 2012-05-14
JP2012110392 2012-05-14
JP2012110394 2012-05-14
JPJP-P-2012-110391 2012-05-14
JPJP-P-2012-110392 2012-05-14
JPJP-P-2012-110393 2012-05-14
JP2012110393 2012-05-14
JPJP-P-2013-003273 2013-01-11
JP2013003273 2013-01-11
PCT/JP2013/063872 WO2013172472A1 (ja) 2012-05-14 2013-05-13 シート成形体および止血材

Publications (2)

Publication Number Publication Date
KR20150020536A KR20150020536A (ko) 2015-02-26
KR102259117B1 true KR102259117B1 (ko) 2021-05-31

Family

ID=49583870

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020147031716A Active KR102259117B1 (ko) 2012-05-14 2013-05-13 시트 성형체 및 지혈재

Country Status (23)

Country Link
US (2) US10485894B2 (cg-RX-API-DMAC10.html)
EP (1) EP2851095B1 (cg-RX-API-DMAC10.html)
JP (2) JP5844894B2 (cg-RX-API-DMAC10.html)
KR (1) KR102259117B1 (cg-RX-API-DMAC10.html)
CN (1) CN104271164B (cg-RX-API-DMAC10.html)
AR (1) AR091031A1 (cg-RX-API-DMAC10.html)
AU (1) AU2013261312B2 (cg-RX-API-DMAC10.html)
BR (1) BR112014028471B8 (cg-RX-API-DMAC10.html)
CA (1) CA2873162C (cg-RX-API-DMAC10.html)
DK (1) DK2851095T3 (cg-RX-API-DMAC10.html)
ES (1) ES2890098T3 (cg-RX-API-DMAC10.html)
HU (1) HUE056396T2 (cg-RX-API-DMAC10.html)
IL (1) IL235689B (cg-RX-API-DMAC10.html)
MX (1) MX357254B (cg-RX-API-DMAC10.html)
MY (1) MY173719A (cg-RX-API-DMAC10.html)
NZ (1) NZ631084A (cg-RX-API-DMAC10.html)
PH (1) PH12014502535A1 (cg-RX-API-DMAC10.html)
PL (1) PL2851095T3 (cg-RX-API-DMAC10.html)
RU (1) RU2669569C2 (cg-RX-API-DMAC10.html)
SG (1) SG11201407549YA (cg-RX-API-DMAC10.html)
TW (1) TWI584825B (cg-RX-API-DMAC10.html)
WO (1) WO2013172472A1 (cg-RX-API-DMAC10.html)
ZA (1) ZA201408258B (cg-RX-API-DMAC10.html)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR091031A1 (es) * 2012-05-14 2014-12-30 Teijin Ltd Producto en planchas y material hemostatico
MX384582B (es) * 2015-11-06 2025-03-14 Ethicon Inc Agregados celulósicos hemostáticos compactados.
EP3427726B1 (en) * 2016-03-07 2023-05-03 Osaka University Sustained drug release sheet for treating nerve injury
CN106267328B (zh) * 2016-09-20 2019-04-12 安徽思维特生物科技有限公司 一种聚己内酯-胎牛皮胶原纤维复合止血凝胶的制备方法
BR112019014236A2 (pt) * 2017-01-23 2020-03-17 Afyx Therapeutics A/S Método para a fabricação de um produto de duas camadas à base de fibras eletrofiadas
KR102029926B1 (ko) * 2017-12-14 2019-10-08 금오공과대학교 산학협력단 풀루란을 이용한 하이드로젤 지혈제 및 그 제조방법
CA3090405A1 (en) * 2018-02-15 2019-08-22 Biom'up France SAS Multi-dimensional hemostatic product and method for producing the same
MX2021011420A (es) 2019-03-20 2021-10-13 Astellas Pharma Inc Lamina hemostatica portadora de trombina.
JP7555981B2 (ja) 2019-07-12 2024-09-25 ガット テクノロジーズ ビー．ブイ． 組織接着性シートを調製するための方法
WO2021009013A1 (en) 2019-07-12 2021-01-21 Gatt Technologies B.V. Biocompatible, flexible, haemostatic sheet
JP7530182B2 (ja) * 2020-02-06 2024-08-07 株式会社東芝 生体適合部材
US12629445B2 (en) 2020-03-20 2026-05-19 Bard Peripheral Vascular, Inc. Reactive hydrogel forming formulations and related methods, including methods of preparation
US11739166B2 (en) 2020-07-02 2023-08-29 Davol Inc. Reactive polysaccharide-based hemostatic agent
US12161777B2 (en) 2020-07-02 2024-12-10 Davol Inc. Flowable hemostatic suspension
WO2022146917A1 (en) 2020-12-28 2022-07-07 Davol Inc. Reactive dry powdered hemostatic materials comprising a protein and a multifunctionalized modified polyethylene glycol based crosslinking agent
EP4456935A1 (en) 2021-12-30 2024-11-06 Baxter International Inc. Fibrinogen and thrombin solutions for a fibrin sealant and fibrin sealant kit
CN117771417A (zh) * 2022-09-29 2024-03-29 苏州泽璟生物制药股份有限公司 一种含重组人凝血酶的生物可降解止血粉及其制备方法和用途
WO2025144087A1 (ru) * 2023-12-24 2025-07-03 Олег ЕВСЕЕНКОВ Гемостатическое средство
CN118236562A (zh) * 2024-03-21 2024-06-25 额尔德木图 一种凝血酶涂层医用弹簧圈的制备方法

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002513645A (ja) * 1998-05-07 2002-05-14 ジェンザイム・コーポレーション 止血化合物および生体吸収性ポリマーを含む組成物
JP2006501949A (ja) 2002-10-04 2006-01-19 ナノマトリックス，インコーポレイテッド 皮膚およびその他の組織のためのシーラント
WO2006028244A1 (ja) 2004-09-07 2006-03-16 Teijin Limited 生体吸収性多孔体
WO2007110783A2 (en) * 2006-03-28 2007-10-04 Gustavo Larsen Method of manufacturing fibrous hemostatic bandages
US20090192429A1 (en) 2007-12-06 2009-07-30 Nanosys, Inc. Resorbable nanoenhanced hemostatic structures and bandage materials
JP2012087122A (ja) 2010-10-19 2012-05-10 Tyco Healthcare Group Lp 治療剤の送達のための自己支持型フィルム

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3105624A1 (de) 1981-02-16 1982-09-02 Hormon-Chemie München GmbH, 8000 München Material zum abdichten und heilen von wunden
SE439078B (sv) 1984-07-17 1985-05-28 Philips Norden Ab Anordning vid en avstembar magnetron
DE19521324C1 (de) 1995-06-12 1996-10-31 Immuno Ag Gewebeklebstoff und Verwendung desselben als Hämostyptikum
US5702715A (en) * 1995-10-27 1997-12-30 Drying Technology Reinforced biological sealants
EP0835667B1 (en) 1996-03-15 2005-11-09 Juridical Foundation The Chemo-Sero-Therapeutic Research Institute Spray device for applying tissue adhesive
ATE439150T1 (de) 1997-11-17 2009-08-15 Haemacure Corp Ein hyaluronsäurederivat enthaltende fibrinsiegel-oder fibrinklebmasse
US6762336B1 (en) 1998-01-19 2004-07-13 The American National Red Cross Hemostatic sandwich bandage
JP4480270B2 (ja) 1998-05-19 2010-06-16 ジ・アメリカン・ナショナル・レッド・クロス 止血サンドウィッチ包帯
PL206194B1 (pl) * 2001-01-25 2010-07-30 Nycomed Pharma Asnycomed Pharma As Sposób wytwarzania zawiesiny cząstek fibrynogenu i trombiny, zawiesina zawierająca fibrynogen, trombinę i alkohol oraz sposób powlekania nośnika taką zawiesiną
US7135189B2 (en) 2001-08-23 2006-11-14 Boston Scientific Scimed, Inc. Compositions and techniques for localized therapy
US20030198659A1 (en) * 2001-10-25 2003-10-23 Hoffmann Michael P. Fibrous pest control
US20040101546A1 (en) * 2002-11-26 2004-05-27 Gorman Anne Jessica Hemostatic wound dressing containing aldehyde-modified polysaccharide and hemostatic agents
WO2004043503A1 (ja) * 2002-11-14 2004-05-27 Juridical Foundation The Chemo-Sero-Therapeutic Research Institute トロンビン固定化生体吸収性合成不織布
US20060051340A1 (en) 2003-01-20 2006-03-09 Juridical Foundation The Chemo-Sero-Therapeutic Research Institute Hemostatic materials
DE602004026561D1 (de) 2003-02-13 2010-05-27 Teijin Ltd Poröse faser, poröses fasergebilde und herstellungsverfahren
US20070172651A1 (en) 2004-03-16 2007-07-26 Takanori Miyoshi Ultrafine polyactic acid fibers and fiber structure, and process for their production
JP4526851B2 (ja) 2004-03-31 2010-08-18 明彦 谷岡 多糖類のナノスケールの繊維および成形体
KR20070026578A (ko) 2004-05-21 2007-03-08 자이단호진 가가쿠오요비겟세이료호겐쿠쇼 조직 봉합제
ES2530989T3 (es) 2004-10-20 2015-03-09 Ethicon Inc Hemostático absorbible
CA2649081A1 (en) 2006-04-10 2007-10-18 Ethicon, Inc. A reinforced absorbable multilayered hemostatic wound dressing and method of making
US20100254961A1 (en) 2007-09-05 2010-10-07 Taiyokagaku Co., Ltd. Water-soluble electrospun sheet
JP5192254B2 (ja) * 2008-02-08 2013-05-08 一般財団法人化学及血清療法研究所 シート状組織接着剤
WO2009128474A1 (ja) 2008-04-16 2009-10-22 財団法人化学及血清療法研究所 トロンビン固定化生体吸収性シート製剤の製造方法
JP2010069031A (ja) * 2008-09-19 2010-04-02 Chemo Sero Therapeut Res Inst シート状フィブリン糊接着剤
WO2010143711A1 (ja) 2009-06-11 2010-12-16 一般財団法人化学及血清療法研究所 創傷被覆材
EP2477617B1 (en) * 2009-09-18 2018-01-31 Bioinspire Technologies Inc. Free-standing biodegradable patch
US8349354B2 (en) * 2009-09-22 2013-01-08 Ethicon, Inc. Composite layered hemostasis device
US8273369B2 (en) * 2010-05-17 2012-09-25 Ethicon, Inc. Reinforced absorbable synthetic matrix for hemostatic applications
US8329211B2 (en) 2010-05-17 2012-12-11 Ethicon, Inc. Reinforced absorbable multi-layered fabric for hemostatic applications
JP5889188B2 (ja) * 2010-07-20 2016-03-22 一般財団法人化学及血清療法研究所 組織接着用シート製剤
JP5905590B2 (ja) 2011-10-26 2016-04-20 エルジー エレクトロニクス インコーポレイティド 無線通信システムにおける制御チャネルを割り当てる方法及び装置
KR102037555B1 (ko) * 2012-05-14 2019-10-28 데이진 가부시키가이샤 멸균 조성물
AR091031A1 (es) * 2012-05-14 2014-12-30 Teijin Ltd Producto en planchas y material hemostatico

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002513645A (ja) * 1998-05-07 2002-05-14 ジェンザイム・コーポレーション 止血化合物および生体吸収性ポリマーを含む組成物
JP2006501949A (ja) 2002-10-04 2006-01-19 ナノマトリックス，インコーポレイテッド 皮膚およびその他の組織のためのシーラント
WO2006028244A1 (ja) 2004-09-07 2006-03-16 Teijin Limited 生体吸収性多孔体
WO2007110783A2 (en) * 2006-03-28 2007-10-04 Gustavo Larsen Method of manufacturing fibrous hemostatic bandages
US20090192429A1 (en) 2007-12-06 2009-07-30 Nanosys, Inc. Resorbable nanoenhanced hemostatic structures and bandage materials
JP2012087122A (ja) 2010-10-19 2012-05-10 Tyco Healthcare Group Lp 治療剤の送達のための自己支持型フィルム

Also Published As

Publication number Publication date
JP2016073641A (ja) 2016-05-12
KR20150020536A (ko) 2015-02-26
PH12014502535B1 (en) 2015-01-21
AR091031A1 (es) 2014-12-30
CA2873162C (en) 2021-07-27
BR112014028471B1 (pt) 2020-05-05
EP2851095A1 (en) 2015-03-25
HUE056396T2 (hu) 2022-02-28
JPWO2013172472A1 (ja) 2016-01-12
CA2873162A1 (en) 2013-11-21
PH12014502535A1 (en) 2015-01-21
TW201406410A (zh) 2014-02-16
ZA201408258B (en) 2015-10-28
US20150151020A1 (en) 2015-06-04
RU2669569C2 (ru) 2018-10-12
IL235689A0 (en) 2015-01-29
DK2851095T3 (da) 2021-09-13
AU2013261312B2 (en) 2016-11-17
WO2013172472A1 (ja) 2013-11-21
BR112014028471B8 (pt) 2020-05-26
HK1204774A1 (en) 2015-12-04
AU2013261312A1 (en) 2015-03-05
US11433160B2 (en) 2022-09-06
MX2014013817A (es) 2015-05-11
JP5844894B2 (ja) 2016-01-20
ES2890098T3 (es) 2022-01-17
US20200046877A1 (en) 2020-02-13
EP2851095A4 (en) 2015-06-17
EP2851095B1 (en) 2021-07-14
NZ631084A (en) 2016-06-24
US10485894B2 (en) 2019-11-26
JP6277172B2 (ja) 2018-02-07
MY173719A (en) 2020-02-18
BR112014028471A2 (pt) 2018-07-17
RU2014150544A (ru) 2016-07-10
SG11201407549YA (en) 2014-12-30
CN104271164B (zh) 2017-11-17
PL2851095T3 (pl) 2022-01-10
IL235689B (en) 2021-10-31
TWI584825B (zh) 2017-06-01
CN104271164A (zh) 2015-01-07
MX357254B (es) 2018-07-03

Similar Documents

Publication Publication Date Title
US11433160B2 (en) Formed sheet product and hemostatic material
Ali et al. Design, development, in-vitro and in-vivo evaluation of polylactic acid-based multifunctional nanofibrous patches for efficient healing of diabetic wounds
Singaravelu et al. Durable keratin-based bilayered electrospun mats for wound closure
KR102037555B1 (ko) 멸균 조성물
KR101733865B1 (ko) 전기방사형 고분자 섬유를 포함하는 지혈재 및 그 제조방법
RU2678828C2 (ru) Белковая композиция, устойчивая к стерилизации облучением
Mukherjee et al. Unlocking the potential of engineered biopolymer-based nanofibers for the management of diabetic wounds: a review
JP5927061B2 (ja) シート状止血材
JP5589080B2 (ja) フィブリン糊と繊維成形体との複合体
JPWO2012011429A1 (ja) 組織接着用シート製剤
EP3981443A1 (en) Improved wound dressings, methods for making these, and uses thereof
HK1204774B (en) Sheet molding and hemostatic material
JP5479584B2 (ja) 生体糊用補強材及びその製造方法
JP5856785B2 (ja) 止血効果に優れたシート状止血材
WO2012023594A1 (ja) 低帯電性繊維およびその製造方法

Legal Events

Date Code Title Description
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

R18-X000 Changes to party contact information recorded

St.27 status event code: A-3-3-R10-R18-oth-X000

A201 Request for examination
PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

R18-X000 Changes to party contact information recorded

St.27 status event code: A-3-3-R10-R18-oth-X000

N231 Notification of change of applicant
PN2301 Change of applicant

St.27 status event code: A-3-3-R10-R13-asn-PN2301

St.27 status event code: A-3-3-R10-R11-asn-PN2301

D13-X000 Search requested

St.27 status event code: A-1-2-D10-D13-srh-X000

D14-X000 Search report completed

St.27 status event code: A-1-2-D10-D14-srh-X000

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

AMND Amendment
P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

E90F Notification of reason for final refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

E601 Decision to refuse application
PE0601 Decision on rejection of patent

St.27 status event code: N-2-6-B10-B15-exm-PE0601

X091 Application refused [patent]
AMND Amendment
P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PX0901 Re-examination

St.27 status event code: A-2-3-E10-E12-rex-PX0901

PX0701 Decision of registration after re-examination

St.27 status event code: A-3-4-F10-F13-rex-PX0701

X701 Decision to grant (after re-examination)
GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U12-oth-PR1002

Fee payment year number: 1

PG1601 Publication of registration

St.27 status event code: A-4-4-Q10-Q13-nap-PG1601

PN2301 Change of applicant

St.27 status event code: A-5-5-R10-R11-asn-PN2301

PN2301 Change of applicant

St.27 status event code: A-5-5-R10-R14-asn-PN2301

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 4

PN2301 Change of applicant

St.27 status event code: A-5-5-R10-R11-asn-PN2301

PN2301 Change of applicant

St.27 status event code: A-5-5-R10-R14-asn-PN2301

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 5

U11 Full renewal or maintenance fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U11-OTH-PR1001 (AS PROVIDED BY THE NATIONAL OFFICE)

Year of fee payment: 5